Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Glial Cell Tumors

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Glial Cell Tumors in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baerwald, R; Cordes, M; Gerlach, L; Maier-Hauff, K1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Glial Cell Tumors

ArticleYear
Cerebral blood flow measurements with HMPAO- and HIPDM-SPECT in brain tumors: basic rCBF studies.
    Psychiatry research, 1989, Volume: 29, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Cerebrovascular Circulation; Female; Glioma; Humans; Iodobenzenes; Lymphoma; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Organotechnetium Compounds; Oximes; Regional Blood Flow; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1989